A case of inoperable advanced gastric cancer remarkably responding to combined chemotherapy with UFT-E, MMC and PSK

A. Kogure, S. Ishii, T. Kakefuda, K. Aiura, Y. Arisawa, Yuukou Kitagawa, M. Nakagawa, N. Shirasugi, K. Noga

Research output: Contribution to journalArticle

Abstract

A 55-year-old male consulted a local doctor with the complaint of epigastralgia. Examination of the upper gastrointestinal tract revealed gastric cancer (Borrmann Type II) and he was referred to our hospital for operation. A few lymph nodes were palpable in the left supraclavicular fossa, and the biopsy of those lymph nodes revealed metastatic adenocarcinoma. The CT scan of the abdomen showed enlargement of paraaortic lymph nodes. Then, the patient was determined inoperable (T 3, N 4, H 0, P 0, M 1 stage IVb). He was treated as an outpatient with UFT-E (300 mg/day, orally), Krestin (PSK 3.0 g/day, orally) and Mitomycin C (MMC 6 or 8 mg once a week, intravenously repeated interval of 4 weeks). The total dose of UFT-E, PSK and MMC was 219 g, 1,095 g and 136 mg, respectively. One month later, lymph nodes in the supraclavicular fossa disappeared, and the lesion in the stomach completely responded. We have followed the patient for more than one year. He visits our the outpatient department and has kept working until now.

Original languageEnglish
Pages (from-to)875-878
Number of pages4
JournalJapanese Journal of Cancer and Chemotherapy
Volume24
Issue number7
Publication statusPublished - 1997
Externally publishedYes

Fingerprint

Stomach Neoplasms
Lymph Nodes
Drug Therapy
Outpatients
Upper Gastrointestinal Tract
Mitomycin
Abdomen
Stomach
Adenocarcinoma
Biopsy
krestin

Keywords

  • Combined chemotherapy
  • Inoperative gastric cancer
  • Virchow lymph node metastasis

ASJC Scopus subject areas

  • Cancer Research
  • Pharmacology

Cite this

A case of inoperable advanced gastric cancer remarkably responding to combined chemotherapy with UFT-E, MMC and PSK. / Kogure, A.; Ishii, S.; Kakefuda, T.; Aiura, K.; Arisawa, Y.; Kitagawa, Yuukou; Nakagawa, M.; Shirasugi, N.; Noga, K.

In: Japanese Journal of Cancer and Chemotherapy, Vol. 24, No. 7, 1997, p. 875-878.

Research output: Contribution to journalArticle

Kogure, A, Ishii, S, Kakefuda, T, Aiura, K, Arisawa, Y, Kitagawa, Y, Nakagawa, M, Shirasugi, N & Noga, K 1997, 'A case of inoperable advanced gastric cancer remarkably responding to combined chemotherapy with UFT-E, MMC and PSK', Japanese Journal of Cancer and Chemotherapy, vol. 24, no. 7, pp. 875-878.
Kogure, A. ; Ishii, S. ; Kakefuda, T. ; Aiura, K. ; Arisawa, Y. ; Kitagawa, Yuukou ; Nakagawa, M. ; Shirasugi, N. ; Noga, K. / A case of inoperable advanced gastric cancer remarkably responding to combined chemotherapy with UFT-E, MMC and PSK. In: Japanese Journal of Cancer and Chemotherapy. 1997 ; Vol. 24, No. 7. pp. 875-878.
@article{7eb96318f78e4a8690618b3f624efbdb,
title = "A case of inoperable advanced gastric cancer remarkably responding to combined chemotherapy with UFT-E, MMC and PSK",
abstract = "A 55-year-old male consulted a local doctor with the complaint of epigastralgia. Examination of the upper gastrointestinal tract revealed gastric cancer (Borrmann Type II) and he was referred to our hospital for operation. A few lymph nodes were palpable in the left supraclavicular fossa, and the biopsy of those lymph nodes revealed metastatic adenocarcinoma. The CT scan of the abdomen showed enlargement of paraaortic lymph nodes. Then, the patient was determined inoperable (T 3, N 4, H 0, P 0, M 1 stage IVb). He was treated as an outpatient with UFT-E (300 mg/day, orally), Krestin (PSK 3.0 g/day, orally) and Mitomycin C (MMC 6 or 8 mg once a week, intravenously repeated interval of 4 weeks). The total dose of UFT-E, PSK and MMC was 219 g, 1,095 g and 136 mg, respectively. One month later, lymph nodes in the supraclavicular fossa disappeared, and the lesion in the stomach completely responded. We have followed the patient for more than one year. He visits our the outpatient department and has kept working until now.",
keywords = "Combined chemotherapy, Inoperative gastric cancer, Virchow lymph node metastasis",
author = "A. Kogure and S. Ishii and T. Kakefuda and K. Aiura and Y. Arisawa and Yuukou Kitagawa and M. Nakagawa and N. Shirasugi and K. Noga",
year = "1997",
language = "English",
volume = "24",
pages = "875--878",
journal = "Japanese Journal of Cancer and Chemotherapy",
issn = "0385-0684",
publisher = "Japanese Journal of Cancer and Chemotherapy Publishers Inc.",
number = "7",

}

TY - JOUR

T1 - A case of inoperable advanced gastric cancer remarkably responding to combined chemotherapy with UFT-E, MMC and PSK

AU - Kogure, A.

AU - Ishii, S.

AU - Kakefuda, T.

AU - Aiura, K.

AU - Arisawa, Y.

AU - Kitagawa, Yuukou

AU - Nakagawa, M.

AU - Shirasugi, N.

AU - Noga, K.

PY - 1997

Y1 - 1997

N2 - A 55-year-old male consulted a local doctor with the complaint of epigastralgia. Examination of the upper gastrointestinal tract revealed gastric cancer (Borrmann Type II) and he was referred to our hospital for operation. A few lymph nodes were palpable in the left supraclavicular fossa, and the biopsy of those lymph nodes revealed metastatic adenocarcinoma. The CT scan of the abdomen showed enlargement of paraaortic lymph nodes. Then, the patient was determined inoperable (T 3, N 4, H 0, P 0, M 1 stage IVb). He was treated as an outpatient with UFT-E (300 mg/day, orally), Krestin (PSK 3.0 g/day, orally) and Mitomycin C (MMC 6 or 8 mg once a week, intravenously repeated interval of 4 weeks). The total dose of UFT-E, PSK and MMC was 219 g, 1,095 g and 136 mg, respectively. One month later, lymph nodes in the supraclavicular fossa disappeared, and the lesion in the stomach completely responded. We have followed the patient for more than one year. He visits our the outpatient department and has kept working until now.

AB - A 55-year-old male consulted a local doctor with the complaint of epigastralgia. Examination of the upper gastrointestinal tract revealed gastric cancer (Borrmann Type II) and he was referred to our hospital for operation. A few lymph nodes were palpable in the left supraclavicular fossa, and the biopsy of those lymph nodes revealed metastatic adenocarcinoma. The CT scan of the abdomen showed enlargement of paraaortic lymph nodes. Then, the patient was determined inoperable (T 3, N 4, H 0, P 0, M 1 stage IVb). He was treated as an outpatient with UFT-E (300 mg/day, orally), Krestin (PSK 3.0 g/day, orally) and Mitomycin C (MMC 6 or 8 mg once a week, intravenously repeated interval of 4 weeks). The total dose of UFT-E, PSK and MMC was 219 g, 1,095 g and 136 mg, respectively. One month later, lymph nodes in the supraclavicular fossa disappeared, and the lesion in the stomach completely responded. We have followed the patient for more than one year. He visits our the outpatient department and has kept working until now.

KW - Combined chemotherapy

KW - Inoperative gastric cancer

KW - Virchow lymph node metastasis

UR - http://www.scopus.com/inward/record.url?scp=0030953408&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0030953408&partnerID=8YFLogxK

M3 - Article

C2 - 9170529

AN - SCOPUS:0030953408

VL - 24

SP - 875

EP - 878

JO - Japanese Journal of Cancer and Chemotherapy

JF - Japanese Journal of Cancer and Chemotherapy

SN - 0385-0684

IS - 7

ER -